Related references
Note: Only part of the references are listed.Long noncoding RNA EGFR-AS1 promotes cell growth and metastasis via affecting HuR mediated mRNA stability of EGFR in renal cancer
Anbang Wang et al.
CELL DEATH & DISEASE (2019)
Nivolumab Alone and With Ipilimumab in Previously Treated Metastatic Urothelial Carcinoma: CheckMate 032 Nivolumab 1 mg/kg Plus Ipilimumab 3 mg/kg Expansion Cohort Results
Padmanee Sharma et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
The lncRNA EGFR-AS1 is linked to migration, invasion and apoptosis in glioma cells by targeting miR-133b/RACK1
Zhi-Qiang Dong et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Increased expression of TRIP13 drives the tumorigenesis of bladder cancer in association with the EGFR signaling pathway
Yanjun Gao et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2019)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
A DDX31/Mutant-p53/EGFR Axis Promotes Multistep Progression of Muscle-Invasive Bladder Cancer
Kei Daizumoto et al.
CANCER RESEARCH (2018)
Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial
Thomas Powles et al.
LANCET (2018)
Long noncoding RNA EGFR-AS1 mediates epidermal growth factor receptor addiction and modulates treatment response in squamous cell carcinoma
Daniel S. W. Tan et al.
NATURE MEDICINE (2017)
Afatinib Activity in Platinum-Refractory Metastatic Urothelial Carcinoma in Patients With ERBB Alterations
Noura J. Choudhury et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Metformin and gefitinib cooperate to inhibit bladder cancer growth via both AMPK and EGFR pathways joining at Akt and Erk
Mei Peng et al.
SCIENTIFIC REPORTS (2016)
A phase 3 study of first-line durvalumab (MEDI4736) ± tremelimumab versus standard of care (SoC) chemotherapy (CT) in patients (pts) with unresectable Stage IV urothelial bladder cancer (UBC): DANUBE
Thomas Powles et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Management of muscle invasive, locally advanced and metastatic urothelial carcinoma of the bladder: a literature review with emphasis on the role of surgery
Mohammad Abufaraj et al.
TRANSLATIONAL ANDROLOGY AND UROLOGY (2016)
S100A9 and EGFR gene signatures predict disease progression in muscle invasive bladder cancer patients after chemotherapy
W. T. Kim et al.
ANNALS OF ONCOLOGY (2014)
Share Paper
